欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/1936/001
药品名称Riastap 1g
活性成分
    • fibrinogen 1.0 g
剂型Powder for solution for infusion/injection
上市许可持有人CSL Behring Emil-von-Behring-Straße 76 35041 Marburg Germany
参考成员国 - 产品名称Germany (DE)
Riastap 1g
互认成员国 - 产品名称
    • Malta (MT)
      Riastap 1g powder for solution for injection/infusion
    • Denmark (DK)
      Riastap
    • Belgium (BE)
    • Luxembourg (LU)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
      Riastap
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Riastap
    • Cyprus (CY)
      RIASTAP PWD FOR SOL FOR INFUSION/INJECTION
    • Slovakia (SK)
      Riastap
    • Slovenia (SI)
许可日期2010/07/27
最近更新日期2024/04/05
药物ATC编码
    • B02BB01 fibrinogen, human
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Biological: Blood Product
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase